Jacqueline Vanderpuye-Orgle

Jacqueline Vanderpuye-Orgle is a seasoned professional in health economics and outcomes research, currently serving as Senior Vice President at Parexel from August 2018 to September 2025. In addition, Jacqueline holds the position of Vice President and has been Chair of the Biosimilars Special Interest Group at ISPOR since March 2019. Prior roles include Chair-elect of the Biosimilars Special Interest Group at Amgen and Sr Manager at Precision Health Economics, where Jacqueline was Director of Research Operations and Senior Research Economist from June 2012 to September 2016. Jacqueline began her career as an Analyst/Underwriter at Endurance Reinsurance Corporation of America from December 2010 to May 2012. Jacqueline earned a Ph.D. in Public Policy Analysis and Management and a Master of Science in Applied Economics and Management, both from Cornell University.